Agalsidase alfa

Details

Files
Generic Name:
Agalsidase alfa
Project Status:
Complete
Therapeutic Area:
Fabry Disease
Manufacturer:
Transkaryotic Therapies Inc.
Brand Name:
Replagal
Project Line:
Reimbursement Review
Project Number:
SR0006-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Fabry Disease
Recommendation Type:
Do not list
Final Recommendation:
Recommendation:
Not to list.